We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
News & ViewsFree Access

Conference Scene: Challenges to commercialization

    Dusko Ilic

    † Author for correspondence

    Embryonic Stem Cell Laboratories, Guy’s Assisted Conception Unit, Division of Reproduction & Endocrinology, King’s College London, UK.

    &
    Eileen Gentleman

    Department of Materials & Institute of Biomedical Engineering, Imperial College London, UK

    Published Online:https://doi.org/10.2217/rme.10.19

    SMi Group Ltd, British business-to-business information provider, organized the second annual Stem Cell Conference in London on 15–16 February, 2010. The conference addressed key scientific developments and the latest updates on therapeutic advances in stem cell application.